Shamburg News · 8-K filed Nov 16, 2026, 7:00 AM EST

Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update

TIL · Instil Bio, Inc.

  • Earnings
  • Materiality: high

Instil Bio, Inc. reported a net loss of $4.2 million, or $0.62 per share, for the quarter ended September 30, 2026, and non-GAAP net loss of $0.48 per share. Cash, cash equivalents, restricted cash, marketable securities and long-term investments totaled $67.1 million as of September 30, 2026, which the company expects will fund its operating plan through 2027. The company also disclosed immaterial errors in prior-period financial statements related to property taxes at its Tarzana, California facility, and has presented 2025 amounts as corrected.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001789769-26-000064.

Written from the filing by Shamburg Markets. Figures are as reported by the company.